Carboxymethylpachymaran enhances immunologic function of dendritic cells cultured in two kinds of hepatoma carcinoma cell line's supernatant via nuclear factor κb/Rel pathway

Chinese Journal of Integrative Medicine

Volumn 18, Issue 3, 2012, Pages 203-208

  Chen, Zhuo ^a   Yu, Bin ^a   Wu, Xian Lin ^a   Dai, Cong Qi ^a   Qian, Guo Qiang ^b   Yu, Jian Zhong ^c   He, Hai Bin ^d   Wang, Zhi Xin ^e   Hou, Jun ^e   Chen, Xiao Yin ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b HUANGHUAI UNIVERSITY   (China)

^c Tongrentang Hospital   (China)

^d Heshan People Hospital   (China)

^e JINAN UNIVERSITY   (China)

Author keywords

Carboxymethylpachymaran; Dendritic cells; Hepatocarcinoma; Lymphocyte subsets; Mixed leukocyte reaction

Indexed keywords

CARBOXYMETHYLPACHYMARAN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12P70; T6 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UMBILICAL CORD; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SHAPE; DENDRITIC CELLS; GLUCANS; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-12; LIVER NEOPLASMS; LYMPHOCYTE CULTURE TEST, MIXED; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TRANSCRIPTION FACTOR RELA;

EID: 84862726371     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0943-4     Document Type: Article

References (18)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-543. (Pubitemid 33586866)
2. Akbar FM, Horiike N, Onji M, Hino O. Dendritic cells and chronic hepatitis virus carriers. Intervirology 2001;44:199-208. (Pubitemid 32757373)
3. Qiu SJ, Lu L, Qiao C, Wang L, Wang Z, Xiao X, et al. Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protin immunization. J Cancer Res Clin Oncol 2005;131:429-438. (Pubitemid 40905020)
4. Caux C, Liu YJ, Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 1995;16:2-4.
5. Zhang YX, Zan YL, Shan M, Liu CM, Shi M, Li M, et al. Effects of heat shock protein gp96 on human dendritic cell maturation and CTL expression. Biochem Biophys Communicat 2006;344:581-587.
6. Eli Gilboa. How tumors escape immune destruction and what we can do about it. Cancer immunology, Immunotherapy 1999;48:382-385. (Pubitemid 29461391)
7. Pardoll D. T cells and tumors. Nature 2001;411:1010-1012.
8. Smyth MJ, Godfrey DI, Trapani JA. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2001;2:293-299. (Pubitemid 33706339)
9. Lee KY, Jeon YL. Polysaccharide isolated from poria cocos sclerotium induces NF-κB/Rel activation and iNOS expression in murine macrophages. Int Immunopharmacol 2003;3:1353-1362. (Pubitemid 37025716)
10. Qian S, Shi M, Zhang H, Zhang B, Xu DP, Wang FS. Phenotype and function of myeloid dendritic cells pulsed with hepatitis B virus antigens in patients with HBVassociated hepatocellular carcinoa. Nat Med J China (Chin) 2005;85:248-252. (Pubitemid 40931961)
11. Kakumu S, Ito S, Ishikawa T, Mita Y, Tagaya T, Fukuzawa Y, et al. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol 2000;15:431-436. (Pubitemid 30262212)
12. Shi M, Qian S, Chen WW, Zhang H, Zhang B, Tang ZR, et al. Hepatitis B virus (HBV) antigen-pulsed monocytederived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro. Clin Exp Immunol 2006;147:277-286. (Pubitemid 46096006)
13. Yu P, Spiot to MT, Lee Y, Schreiber H, Fu YX. Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells. J Exp Med 2003;197:985-995. (Pubitemid 36523196)
14. Cuenca A, Cheng F, Wang H, Brayer J, Horna P, Gu L, et al. Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens. Cancer Res 2003;63:9007-9015. (Pubitemid 38064082)
15. Spiotto MT, Fu YX, Schreiber H. Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation. Curr Opin Immunol 2003;15:725-730. (Pubitemid 37434082)
16. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711. (Pubitemid 37174545)
17. Lu SC, Cao QL, Zhang L. Effect of pachymaran on immunologic function of normal and tumor-bearing mice. J First Milit Med Univ (Chin) 1990;10:267-268.
18. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995;154:5071-5079.